Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
124.3 USD | -9.91% | -4.87% | +0.20% |
05:26pm | Morgan Stanley Adjusts DexCom's Price Target to $132 From $122 | MT |
04:56pm | Canaccord Genuity Adjusts Price Target on DexCom to $145 From $144 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.20% | 54.66B | |
-2.31% | 185B | |
-3.20% | 105B | |
-5.04% | 66.59B | |
+17.29% | 47.78B | |
+4.06% | 41.26B | |
+2.36% | 26.95B | |
+2.07% | 26.37B | |
+12.96% | 24.8B | |
-1.93% | 24.6B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- DexCom Posts Higher Q3 Adjusted Profit, Revenue; Lifts Bottom End of 2022 Revenue Guidance; Shares Rise Friday